Cargando…

Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines

The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhawan, Manish, Rabaan, Ali A., Fawarah, Mahmoud M. Al, Almuthree, Souad A., Alsubki, Roua A., Alfaraj, Amal H., Mashraqi, Mutaib M., Alshamrani, Saleh A., Abduljabbar, Wesam A., Alwashmi, Ameen S. S., Ibrahim, Fatimah Al, Alsaleh, Abdulmonem A., Khamis, Faryal, Alsalman, Jameela, Sharma, Manish, Emran, Talha Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/
https://www.ncbi.nlm.nih.gov/pubmed/36679947
http://dx.doi.org/10.3390/vaccines11010101
_version_ 1784874847877201920
author Dhawan, Manish
Rabaan, Ali A.
Fawarah, Mahmoud M. Al
Almuthree, Souad A.
Alsubki, Roua A.
Alfaraj, Amal H.
Mashraqi, Mutaib M.
Alshamrani, Saleh A.
Abduljabbar, Wesam A.
Alwashmi, Ameen S. S.
Ibrahim, Fatimah Al
Alsaleh, Abdulmonem A.
Khamis, Faryal
Alsalman, Jameela
Sharma, Manish
Emran, Talha Bin
author_facet Dhawan, Manish
Rabaan, Ali A.
Fawarah, Mahmoud M. Al
Almuthree, Souad A.
Alsubki, Roua A.
Alfaraj, Amal H.
Mashraqi, Mutaib M.
Alshamrani, Saleh A.
Abduljabbar, Wesam A.
Alwashmi, Ameen S. S.
Ibrahim, Fatimah Al
Alsaleh, Abdulmonem A.
Khamis, Faryal
Alsalman, Jameela
Sharma, Manish
Emran, Talha Bin
author_sort Dhawan, Manish
collection PubMed
description The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the infection mechanism of SARS-CoV-2 but also for the generation of effective and reliable vaccines against COVID-19. The effectiveness of the vaccine is supported by the adaptive immune response, which mainly consists of B and T cells, which play a critical role in deciding the prognosis of the COVID-19 disease. T cells are essential for reducing the viral load and containing the infection. A plethora of viral proteins can be recognized by T cells and provide a broad range of protection, especially amid the emergence of novel variants of SARS-CoV-2. However, the hyperactivation of the effector T cells and reduced number of lymphocytes have been found to be the key characteristics of the severe disease. Notably, excessive T cell activation may cause acute respiratory distress syndrome (ARDS) by producing unwarranted and excessive amounts of cytokines and chemokines. Nevertheless, it is still unknown how T-cell-mediated immune responses function in determining the prognosis of SARS-CoV-2 infection. Additionally, it is unknown how the functional perturbations in the T cells lead to the severe form of the disease and to reduced protection not only against SARS-CoV-2 but many other viral infections. Hence, an updated review has been developed to understand the involvement of T cells in the infection mechanism, which in turn determines the prognosis of the disease. Importantly, we have also focused on the T cells’ exhaustion under certain conditions and how these functional perturbations can be modulated for an effective immune response against SARS-CoV-2. Additionally, a range of therapeutic strategies has been discussed that can elevate the T cell-mediated immune response either directly or indirectly.
format Online
Article
Text
id pubmed-9861463
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98614632023-01-22 Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines Dhawan, Manish Rabaan, Ali A. Fawarah, Mahmoud M. Al Almuthree, Souad A. Alsubki, Roua A. Alfaraj, Amal H. Mashraqi, Mutaib M. Alshamrani, Saleh A. Abduljabbar, Wesam A. Alwashmi, Ameen S. S. Ibrahim, Fatimah Al Alsaleh, Abdulmonem A. Khamis, Faryal Alsalman, Jameela Sharma, Manish Emran, Talha Bin Vaccines (Basel) Review The emergence of novel variants of SARS-CoV-2 and their abilities to evade the immune response elicited through presently available vaccination makes it essential to recognize the mechanisms through which SARS-CoV-2 interacts with the human immune response. It is essential not only to comprehend the infection mechanism of SARS-CoV-2 but also for the generation of effective and reliable vaccines against COVID-19. The effectiveness of the vaccine is supported by the adaptive immune response, which mainly consists of B and T cells, which play a critical role in deciding the prognosis of the COVID-19 disease. T cells are essential for reducing the viral load and containing the infection. A plethora of viral proteins can be recognized by T cells and provide a broad range of protection, especially amid the emergence of novel variants of SARS-CoV-2. However, the hyperactivation of the effector T cells and reduced number of lymphocytes have been found to be the key characteristics of the severe disease. Notably, excessive T cell activation may cause acute respiratory distress syndrome (ARDS) by producing unwarranted and excessive amounts of cytokines and chemokines. Nevertheless, it is still unknown how T-cell-mediated immune responses function in determining the prognosis of SARS-CoV-2 infection. Additionally, it is unknown how the functional perturbations in the T cells lead to the severe form of the disease and to reduced protection not only against SARS-CoV-2 but many other viral infections. Hence, an updated review has been developed to understand the involvement of T cells in the infection mechanism, which in turn determines the prognosis of the disease. Importantly, we have also focused on the T cells’ exhaustion under certain conditions and how these functional perturbations can be modulated for an effective immune response against SARS-CoV-2. Additionally, a range of therapeutic strategies has been discussed that can elevate the T cell-mediated immune response either directly or indirectly. MDPI 2023-01-01 /pmc/articles/PMC9861463/ /pubmed/36679947 http://dx.doi.org/10.3390/vaccines11010101 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Dhawan, Manish
Rabaan, Ali A.
Fawarah, Mahmoud M. Al
Almuthree, Souad A.
Alsubki, Roua A.
Alfaraj, Amal H.
Mashraqi, Mutaib M.
Alshamrani, Saleh A.
Abduljabbar, Wesam A.
Alwashmi, Ameen S. S.
Ibrahim, Fatimah Al
Alsaleh, Abdulmonem A.
Khamis, Faryal
Alsalman, Jameela
Sharma, Manish
Emran, Talha Bin
Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title_full Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title_fullStr Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title_full_unstemmed Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title_short Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
title_sort updated insights into the t cell-mediated immune response against sars-cov-2: a step towards efficient and reliable vaccines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861463/
https://www.ncbi.nlm.nih.gov/pubmed/36679947
http://dx.doi.org/10.3390/vaccines11010101
work_keys_str_mv AT dhawanmanish updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT rabaanalia updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT fawarahmahmoudmal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT almuthreesouada updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alsubkirouaa updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alfarajamalh updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT mashraqimutaibm updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alshamranisaleha updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT abduljabbarwesama updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alwashmiameenss updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT ibrahimfatimahal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alsalehabdulmonema updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT khamisfaryal updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT alsalmanjameela updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT sharmamanish updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines
AT emrantalhabin updatedinsightsintothetcellmediatedimmuneresponseagainstsarscov2asteptowardsefficientandreliablevaccines